| 07:00 - 08:15 | 207 | Harnessing digital technology to improve the lives of patients with respiratory disease | Early Morning Symposium |
| 07:00 - 08:15 | 208 | CCC Respiratory infections | Challenging clinical cases |
| 07:00 - 08:15 | 209 | CCC Pulmonary vascular diseases | Challenging clinical cases |
| 08:30 - 10:30 | 214 | State of the art session: Pulmonary vascular diseases | Symposium |
| 08:30 - 10:30 | 215 | Paediatric Grand Round | Grand round |
| 08:30 - 10:30 | 216 | Recent developments and future perspectives in the diagnosis and treatment of tuberculosis | Symposium |
| 08:30 - 10:30 | 217 | Advances in care and monitoring of cystic fibrosis | Oral Presentation |
| 08:30 - 10:30 | 218 | The Global Burden of Disease, Global Alliance for Chronic Diseases and Forum of International Respiratory Societies and other international initiatives | Hot topic |
| 08:30 - 10:30 | 219 | It takes two to tango: translating scientific findings into clinical applications | Symposium |
| 08:30 - 10:30 | 220 | European guidelines for malignant pleural mesothelioma management in 2019 | Guidelines session |
| 08:30 - 10:30 | 221 | Interstitial lung diseases? | Lungs on fire |
| 08:30 - 10:30 | 222 | Integrated strategies for acute non-invasive ventilation | Symposium |
| 08:30 - 10:30 | 223 | Understanding lung disease: novel in vitro models | Oral Presentation |
| 08:30 - 10:30 | 224 | Diagnostic procedures and biology of lung cancer | Oral Presentation |
| 08:30 - 10:30 | 225 | Imaging of airway diseases | Oral Presentation |
| 08:30 - 10:30 | 226 | The evolving field of idiopathic interstitial pneumonia | Oral Presentation |
| 08:30 - 10:30 | 227 | Imaging: new insights that pulmonologists should be aware of | Oral Presentation |
| 08:30 - 10:30 | 228 | Long-term lung function: from early birth to adulthood | Oral Presentation |
| 08:30 - 10:30 | 229 | Granulomatous disorders: pathogenesis, epidemiology and clinical issues | Poster Discussion |
| 08:30 - 10:30 | 230 | How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness | Poster Discussion |
| 08:30 - 10:30 | 231 | Air pollution and respiratory health | Poster Discussion |
| 08:30 - 10:30 | 232 | Current perspectives in sleep-disordered breathing | Poster Discussion |
| 08:30 - 10:30 | 233 | Clinical problems from non-malignant pleural disease to hypoventilation | Poster Discussion |
| 08:30 - 10:30 | 234 | Advances in COPD pharmacology | Poster Discussion |
| 10:40 - 13:00 | 240 | SW13 Recent advances in oscillometry | Skills workshop |
| 10:45 - 12:45 | 242 | Clinical Grand Round | Grand round |
| 10:45 - 12:45 | 243 | State of the art session: Sleep and breathing disorders | Symposium |
| 10:45 - 12:45 | 244 | Improving respiratory health through education | Symposium |
| 10:45 - 12:45 | 245 | New recommendations and priorities for asthma management | Hot topic |
| 10:45 - 12:45 | 246 | Tracheobronchomalacia in children | Hot topic |
| 10:45 - 12:45 | 247 | Preventing childhood asthma in the digital era: harnessing the potential of exposome components for public health | Symposium |
| 10:45 - 12:45 | 248 | Update on anticoagulant therapy: controversy and progress | Symposium |
| 10:45 - 12:45 | 249 | Lung cancer? | Lungs on fire |
| 10:45 - 12:45 | 250 | New towards old therapies in airway diseases | Oral Presentation |
| 10:45 - 12:45 | 251 | Damage and remodelling in pulmonary fibrosis | Oral Presentation |
| 10:45 - 12:45 | 252 | Injury and repair: less is more | Oral Presentation |
| 10:45 - 12:45 | 253 | ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension | Clinical trials session |
| 10:45 - 12:45 | 254 | Drug-resistant tuberculosis | Oral Presentation |
| 10:45 - 12:45 | 255 | Towards a better understanding of rare diffuse parenchymal lung diseases | Oral Presentation |
| 10:45 - 12:45 | 256 | Eosinophils and FeNO in airway diseases | Oral Presentation |
| 10:45 - 12:45 | 257 | Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection | Poster Discussion |
| 10:45 - 12:45 | 258 | ECMO, ECCO2R and other rescue therapies in acute respiratory failure | Poster Discussion |
| 10:45 - 12:45 | 259 | Assessment and training of respiratory muscles | Poster Discussion |
| 10:45 - 12:45 | 260 | Thoracic surgery | Poster Discussion |
| 10:45 - 12:45 | 261 | M-health/e-health I | Poster Discussion |
| 10:45 - 12:45 | 262 | Biomarkers and beyond in idiopathic interstitial pneumonia | Poster Discussion |
| 12:50 - 14:40 | 266 | Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure | Thematic Poster |
| 12:50 - 14:40 | 267 | COPD and other specific entities in intensive care unit medicine | Thematic Poster |
| 12:50 - 14:40 | 268 | Treatment of chronic respiratory failure with noninvasive ventilation | Thematic Poster |
| 12:50 - 14:40 | 269 | Treatment of acute respiratory failure with noninvasive ventilation | Thematic Poster |
| 12:50 - 14:40 | 270 | Novel methods, diagnostics and biomarkers in chronic lung diseases | Thematic Poster |
| 12:50 - 14:40 | 271 | Identification of new targets and therapeutic strategies for lung disease | Thematic Poster |
| 12:50 - 14:40 | 272 | Host-microbe interactions in lung disease and exacerbations | Thematic Poster |
| 12:50 - 14:40 | 273 | Effects of environmental exposures in lung pathology and the underlying mechanisms | Thematic Poster |
| 12:50 - 14:40 | 274 | New mechanistic insights into pulmonary fibrosis | Thematic Poster |
| 12:50 - 14:40 | 275 | Involvement of the environment and inflammation in pulmonary remodelling | Thematic Poster |
| 12:50 - 14:40 | 276 | COPD treatment: cardiovascular, oxygen and vaccination studies | Thematic Poster |
| 12:50 - 14:40 | 277 | COPD clinical trials: inhaled and oral therapies | Thematic Poster |
| 12:50 - 14:40 | 278 | COPD treatment: cohorts and real-world studies | Thematic Poster |
| 12:50 - 14:40 | 279 | Real-world experience of monoclonal antibodies in asthma | Thematic Poster |
| 12:50 - 14:40 | 280 | Clinical studies of asthma treatments | Thematic Poster |
| 12:50 - 14:40 | 281 | Asthma treatment: cohorts and real-world studies | Thematic Poster |
| 12:50 - 14:40 | 282 | Airway diseases and blood cells | Thematic Poster |
| 12:50 - 14:40 | 283 | Long-term evaluation and control of airway diseases | Thematic Poster |
| 12:50 - 14:40 | 284 | FeNO in airway diseases and asthma-COPD overlap identification | Thematic Poster |
| 12:50 - 14:40 | 285 | Physiologic assessment of airway diseases | Thematic Poster |
| 12:50 - 14:40 | 286 | Cardiovascular comorbidities in COPD | Thematic Poster |
| 12:50 - 14:40 | 287 | Bronchiectasis | Thematic Poster |
| 12:50 - 14:40 | 288 | Clinical implications of COPD management | Thematic Poster |
| 12:50 - 14:40 | 289 | Clinical approach to asthma management | Thematic Poster |
| 12:50 - 14:40 | 290 | Asthma and allergies worldwide | Thematic Poster |
| 12:50 - 14:40 | 291 | Clinical aspects of airway diseases | Thematic Poster |
| 12:50 - 14:40 | 292 | Asthma epidemiology in the 21st century | Thematic Poster |
| 12:50 - 14:40 | 293 | Tuberculosis epidemiology, bronchiectasis, other infections and spirometry | Thematic Poster |
| 12:50 - 14:40 | 294 | Environment, work and respiratory health in occupational and environmental lung diseases | Thematic Poster |
| 12:50 - 14:40 | 295 | Air pollution and the lungs | Thematic Poster |
| 12:50 - 14:40 | 296 | Tobacco cessation interventions in different settings and populations | Thematic Poster |
| 12:50 - 14:40 | 297 | Phenotypes and endotypes of bronchiectasis | Thematic Poster |
| 12:50 - 14:40 | 298 | Airway infection in COPD | Thematic Poster |
| 12:50 - 14:40 | 299 | Severe pneumonia: epidemiology, mechanisms and treatment | Thematic Poster |
| 12:50 - 14:40 | 300 | Clinical investigations of non-TB mycobacterial infection | Thematic Poster |
| 12:50 - 14:40 | 301 | Tuberculosis: from diagnosis to complications | Thematic Poster |
| 12:50 - 14:40 | 302 | Tuberculosis and comorbidities | Thematic Poster |
| 12:50 - 14:40 | 303 | Extra-pulmonary tuberculosis and comorbidities | Thematic Poster |
| 12:50 - 14:40 | 304 | Tuberculosis: diagnosis | Thematic Poster |
| 12:50 - 14:40 | 305 | Early detection, follow-up and epidemiology of lung cancer | Thematic Poster |
| 12:50 - 14:40 | 306 | Biology and prognosis of lung cancer | Thematic Poster |
| 12:50 - 14:40 | 307 | Diagnosis of lung cancer | Thematic Poster |
| 12:50 - 14:40 | 308 | Pleural disease: applying the evidence | Thematic Poster |
| 12:50 - 14:40 | 309 | Interventional pulmonology techniques: targeting selective lung tissue | Thematic Poster |
| 12:50 - 14:40 | 310 | Interventional pulmonology: current pleural practice | Thematic Poster |
| 12:50 - 14:40 | 311 | Interventional pulmonology: re-sculpting the airway | Thematic Poster |
| 12:50 - 14:40 | 312 | Imaging in respiratory disease: novel technologies in 2019 | Thematic Poster |
| 13:00 - 14:30 | 314 | Tuberculosis: latest advances and challenges in patient management | Lunchtime session |
| 13:00 - 14:00 | 321 | ME4 Brain metastases in lung cancer patients. | Meet the expert |
| 13:00 - 14:00 | 322 | ME5 Tick tock: impact of circadian clocks on airway diseases | Meet the expert |
| 13:00 - 14:00 | 323 | ME6 Patient-ventilator interaction: tricks and tips | Meet the expert |
| 13:00 - 14:30 | 10796 | Vaping-induced lung disease: what the respiratory health-care provider needs to know? | Hot topic |
| 14:45 - 16:45 | 338 | State of the art session: Airway disease | Symposium |
| 14:45 - 16:45 | 339 | The best of the European Respiratory Journal in 2019 | Symposium |
| 14:45 - 16:45 | 340 | New guidelines for treatment of nontuberculous mycobacterial pulmonary disease | Guidelines session |
| 14:45 - 16:45 | 341 | Molecular profiling and personalised treatment concepts in advanced non-small cell lung cancer: pertinent clinical dilemmas | Symposium |
| 14:45 - 16:45 | 342 | Obesity: pathophysiology, diagnostic challenges and multidisciplinary treatment | Symposium |
| 14:45 - 16:45 | 343 | Lungs in the fog | Symposium |
| 14:45 - 16:45 | 344 | Therapeutic breakthrough Year in review | Year in review |
| 14:45 - 16:45 | 345 | Paediatric respiratory diseases | Lungs on fire |
| 14:45 - 16:45 | 346 | From 2D to 3D models of human lung disease: novel developments to rebuild the lung | Symposium |
| 14:45 - 16:45 | 347 | Challenging issues in the clinical aspects of sleep-disordered breathing | Oral Presentation |
| 14:45 - 16:45 | 348 | Occupational lung diseases: from diagnostic techniques to classical and novel causes | Oral Presentation |
| 14:45 - 16:45 | 349 | Asthma and COPD comorbidities | Oral Presentation |
| 14:45 - 16:45 | 350 | Acute respiratory distress syndrome: developments in diagnostics and outcomes | Oral Presentation |
| 14:45 - 16:45 | 351 | Pneumonia in 2019: antimicrobial resistance, cardiovascular complications and diagnosis | Oral Presentation |
| 14:45 - 16:45 | 352 | From the health effects of tobacco to the epidemiology of tobacco/electronic nicotine delivery system use | Oral Presentation |
| 14:45 - 16:45 | 353 | COPD: epidemiology and spirometry | Poster Discussion |
| 14:45 - 16:45 | 354 | Understanding the mechanisms underlying airway diseases | Poster Discussion |
| 14:45 - 16:45 | 355 | Lung transplantation: from basic science to clinical outcomes | Poster Discussion |
| 14:45 - 16:45 | 356 | COPD clinical studies: bronchodilators, corticosteroids and more | Poster Discussion |
| 14:45 - 16:45 | 357 | New insights into pleural and bronchoscopic interventions | Poster Discussion |
| 14:45 - 16:45 | 358 | Hot topics in pulmonary rehabilitation | Poster Discussion |
| 15:00 - 16:30 | 359 | ERS Women leaders | Symposium |
| 17:15 - 19:15 | 364 | New Horizons in The Treatment of Pulmonary Fibrosis | Evening Symposium |
| 17:15 - 19:15 | 369 | The journey towards personalized medicine in asthma: where are we now? | Evening Symposium |